Twitter | Pretraživanje | |
Cydan
Cydan, an orphan drug accelerator dedicated to creating therapies that improve the lives of patients living with rare genetic diseases.
252
Tweetovi
570
Pratim
391
Osobe koje vas prate
Tweetovi
Cydan 14. sij
Proud to participate and sponsor Rare In the Square. Thanks to Global Genes and the other sponsors for bringing this important event to
Reply Retweet Označi sa "sviđa mi se"
Cydan proslijedio/la je tweet
Yael Gruenbaum-Cohen 14. sij
What a beautiful evening with my huge hearted friends from the industry. Patient oriented pharma going global
Reply Retweet Označi sa "sviđa mi se"
Cydan 13. sij
Cydan is excited to support Global Genes at the Rare in the Square event at
Reply Retweet Označi sa "sviđa mi se"
Cydan proslijedio/la je tweet
Sara Nayeem 14. stu
Odgovor korisniku/ci @SaraNayeem
Finally, ind. BOD members w/ the most orthogonal insights are also often least in-the-know on key operational aspects of the business. This can result in them disengaging, not speaking up much, etc. One way to address this to ask outside of mtgs what THEY see as risks/opp's. 5/5
Reply Retweet Označi sa "sviđa mi se"
Cydan proslijedio/la je tweet
James McArthur 13. stu
Cydan is pleased to support the 2019 IARC meeting in DC & collaborating to create new Rx for ataxias. This IARC is the largest ever with more companies, investigators and advocacy groups than any previous IARC. Congratulations
Reply Retweet Označi sa "sviđa mi se"
Cydan 24. lis
Cydan congratulates all the participants at MassChallenge 2019 to and is excited to support entrepreneurship
Reply Retweet Označi sa "sviđa mi se"
Cydan 1. lis
We're proud to have attended the Energy Ball! Pictured here is Ronald J. Bartek, President/Director/Co-Founder of FARA, and James McArthur, Founder and President of Cydan.
Reply Retweet Označi sa "sviđa mi se"
Cydan 29. ruj
Odgovor korisniku/ci @cdnjamesg @CureFA_org
Dapper gents! Enjoy the celebration 🎉!
Reply Retweet Označi sa "sviđa mi se"
Cydan 19. ruj
We're excited to be participating in the Global Genes Rare Patient Advocacy Summit. If you're attending, swing by Imran's panel - Friday September 20 at 1:00
Reply Retweet Označi sa "sviđa mi se"
Cydan 26. kol
James and Ryan had a great time this weekend at Cycle 4 CMT, a fundraising ride for Charcot-Marie-Tooth, or CMT. If you’re interested in helping, consider donating at
Reply Retweet Označi sa "sviđa mi se"
Cydan 23. kol
This Saturday we’ll be riding for a good cause and fundraising to find a cure for people with Charcot-Marie-Tooth, or CMT, a progressive neurological disease. If you’re interested in helping, consider donating at
Reply Retweet Označi sa "sviđa mi se"
Cydan 14. kol
Please support the Cydan Cycling Team to support the CMT Association!
Reply Retweet Označi sa "sviđa mi se"
Cydan 26. srp
Cydan is excited to participate at the annual HNRNPH2 family meeting. Great scientific progress and increase in rate of patient identification => 100 patients soon!
Reply Retweet Označi sa "sviđa mi se"
Cydan 25. srp
Inspiring progress congrats Rohan - the Lydian Accelerator is moving at warp speed!
Reply Retweet Označi sa "sviđa mi se"
Cydan 11. srp
Our Co-Founder and President R&D, James McArthur, has been a part of the FARA board of directors and scientific advisory board for the last several years as part of our commitment to help advance meaningful treatments for patients with rare genetic diseases.
Reply Retweet Označi sa "sviđa mi se"
Cydan 5. srp
Happy Independence Day! Watch this inspiring story of the Seth family’s quest to accelerate a therapy to save their daughter Lydia
Reply Retweet Označi sa "sviđa mi se"
Cydan proslijedio/la je tweet
Big4Bio:Boston 3. srp
Reply Retweet Označi sa "sviđa mi se"
Cydan 19. lip
Odgovor korisniku/ci @ImaraInc @EHA_Hematology
Great progress for Imara!
Reply Retweet Označi sa "sviđa mi se"
Cydan 13. lip
If you're attending the today, 's Imran Babar, PhD, will be part of a panel discussion during the Partnering & Investment track at 1:45 p.m. Under its collaborative model, Cydan has launched three new companies focused on rare disease.
Reply Retweet Označi sa "sviđa mi se"
Cydan 11. lip
's Imran Babar, PhD will be in Boston at the tomorrow to participate in a panel discussion on funding rare disease therapies. Cydan works with leading investors in to accelerate science to medicine.
Reply Retweet Označi sa "sviđa mi se"